147 related articles for article (PubMed ID: 33793959)
1. Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study.
Andres M; Feller A; Arndt V; The Nicer Working Group
Swiss Med Wkly; 2021 Mar; 151():w20463. PubMed ID: 33793959
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
Dores GM; Anderson WF; Curtis RE; Landgren O; Ostroumova E; Bluhm EC; Rabkin CS; Devesa SS; Linet MS
Br J Haematol; 2007 Dec; 139(5):809-19. PubMed ID: 17941952
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015.
Ko BS; Chen LJ; Huang HH; Chen HM; Hsiao FY
Int J Clin Pract; 2021 Aug; 75(8):e14258. PubMed ID: 33884738
[TBL] [Abstract][Full Text] [Related]
5. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.
Solans M; Osca-Gelis G; Comas R; Roncero JM; Gallardo D; Marcos-Gragera R; Saez M
Cancer Causes Control; 2018 Mar; 29(3):379-382. PubMed ID: 29383469
[TBL] [Abstract][Full Text] [Related]
6. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.
Lenartova A; Johannesen TB; Tjønnfjord GE
Cancer Med; 2016 Dec; 5(12):3588-3595. PubMed ID: 27925456
[TBL] [Abstract][Full Text] [Related]
7. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
[TBL] [Abstract][Full Text] [Related]
8. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
9. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
10. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
[TBL] [Abstract][Full Text] [Related]
12. Paediatric end-stage renal disease and renal replacement therapy in Switzerland: survival and treatment trends over four decades.
Maurer E; Neuhaus TJ; Weitz M; Kuehni CE; Laube GF
Swiss Med Wkly; 2020 Jul; 150():w20300. PubMed ID: 32920790
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY; Abd El-Wahed MM; Dawoud MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).
Pfeil AM; Imfeld P; Pettengell R; Jick SS; Szucs TD; Meier CR; Schwenkglenks M
Ann Hematol; 2015 Mar; 94(3):421-9. PubMed ID: 25219890
[TBL] [Abstract][Full Text] [Related]
16. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008.
van den Broek EC; Kater AP; van de Schans SA; Karim-Kos HE; Janssen-Heijnen ML; Peters WG; Nooijen PT; Coebergh JW; Posthuma EF
Eur J Cancer; 2012 Apr; 48(6):889-95. PubMed ID: 21795040
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Wu J; Zhang Y; Sun L; Zhai Q
Pathol Res Pract; 2018 Jan; 214(1):72-75. PubMed ID: 29254788
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
